ResMed shares are trading lower after RBC Capital downgraded the stock from Outperform to Sector Perform and lowered its price target from $273 to $202.
Portfolio Pulse from Benzinga Newsdesk
ResMed's stock has been downgraded from Outperform to Sector Perform by RBC Capital, which also lowered its price target from $273 to $202. This has resulted in ResMed shares trading lower.
October 12, 2023 | 6:14 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
ResMed's stock has been downgraded by RBC Capital, leading to a decrease in its share price. The price target has also been lowered from $273 to $202.
The downgrade from RBC Capital is a negative signal to investors, which can lead to selling pressure and a decrease in the stock price. The lowering of the price target further indicates a less optimistic outlook for the company's stock, which can also negatively impact the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100